FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jan Lehmann

Research Profile

Disorders

Concepts & Ideas

Anatomy

Tumor Cells, Cultured

Chemicals & Drugs

Procedures

Co-author Network

Publications

TOP 3
Henrik Suttmann; Joern Kamradt; Frank Becker; Jan Lehmann; Michael Stöckle
[Extending the limits of lymphadenectomy during radical cystectomy: pitfalls in the interpretation of contemporary study results].
Henrik Suttmann; Aleksandar Grgic; Jan Lehmann; Ulrike Zwergel; Joern Kamradt; Eric Gouverneur; Jörg Pinkert; Michael Stöckle; Carl-Martin Kirsch; Ursula Nestle
Combining 153Sm-lexidronam and docetaxel for the treatment of patients with hormone-refractory prostate cancer: first experience.
Henrik Suttmann; Margitta Retz; Friedrich Paulsen; Jürgen Harder; Ulrike Zwergel; Joern Kamradt; Bernd Wullich; Gerhard Unteregger; Michael Stöckle; Jan Lehmann
Antimicrobial peptides of the Cecropin-family show potent antitumor activity against bladder cancer cells.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jan Lehmann (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Henrik Suttmann; Joern Kamradt; Frank Becker; Jan Lehmann; Michael Stöckle
[Extending the limits of lymphadenectomy during radical cystectomy: pitfalls in the interpretation of contemporary study results].
Der Urologe. Ausg. A 2009;48(2):151-5.
2008: Henrik Suttmann; Aleksandar Grgic; Jan Lehmann; Ulrike Zwergel; Joern Kamradt; Eric Gouverneur; Jörg Pinkert; Michael Stöckle; Carl-Martin Kirsch; Ursula Nestle
Combining 153Sm-lexidronam and docetaxel for the treatment of patients with hormone-refractory prostate cancer: first experience.
Cancer biotherapy & radiopharmaceuticals 2008;23(5):609-18.
2008: Henrik Suttmann; Margitta Retz; Friedrich Paulsen; Jürgen Harder; Ulrike Zwergel; Joern Kamradt; Bernd Wullich; Gerhard Unteregger; Michael Stöckle; Jan Lehmann
Antimicrobial peptides of the Cecropin-family show potent antitumor activity against bladder cancer cells.
BMC urology 2008;8():5.
2007: Henrik Suttmann; Joern Kamradt; Jan Lehmann; Michael Stöckle
Improving the prognosis of patients after radical cystectomy. Part II: the role of perioperative chemotherapy.
BJU international 2007;100(6):1225-8.
2007: Henrik Suttmann; Joern Kamradt; Jan Lehmann; Michael Stöckle
Improving the prognosis of patients after radical cystectomy. Part I: the role of lymph node dissection.
BJU international 2007;100(6):1221-4.
2007: Ulrike Zwergel; Henrik Suttmann; Thomas Schroeder; Stefan Siemer; Bernd Wullich; Joern Kamradt; Jan Lehmann; Michael Stoeckle
Outcome of prostate cancer patients with initial PSA> or =20 ng/ml undergoing radical prostatectomy.
European urology 2007;52(4):1058-65.
2007: Jan Lehmann; Henrik Suttmann; Iva Kovac; Markus Hack; Joern Kamradt; Stefan Siemer; Bernd Wullich; Ulrike Zwergel; Michael Stöckle
Transitional cell carcinoma of the ureter: prognostic factors influencing progression and survival.
European urology 2007;51(5):1281-8.
2006: Jan Lehmann; Henrik Suttmann; M Gerber; R Shayesteh-Kheslat; J Hartmann; M Hack; Stefan Siemer; Michael Stöckle
[Expression of antimicrobial peptide MUC7 in kidneys with pyelonephritis].
Der Urologe. Ausg. A 2006;45(10):1300, 1302-7.
2006: Jan Lehmann; Margitta Retz; Stefan Siemer; Ulrich Schreier; Ulrike Zwergel; Michael Stöckle
Long-term survival under maintenance gemcitabine chemotherapy for metastatic transitional cell carcinoma.
International journal of urology : official journal of the Japanese Urological Association 2006;13(7):1035-6.
2006: Jan Lehmann; Margitta Retz; Sukhvinder S Sidhu; Henrik Suttmann; Michael Sell; Friedrich Paulsen; Jürgen Harder; Gerhard Unteregger; Michael Stöckle
Antitumor activity of the antimicrobial peptide magainin II against bladder cancer cell lines.
European urology 2006;50(1):141-7.
2006: Roland Kindich; Andrea R Florl; Joern Kamradt; Jan Lehmann; Mirko Müller; Bernd Wullich; Wolfgang A Schulz
Relationship of NKX3.1 and MYC gene copy number ratio and DNA hypomethylation to prostate carcinoma stage.
European urology 2006;49(1):169-75; discussion 175.
2005: Jan Lehmann; A Böhle
[Clinical trials for bladder cancer in Germany].
Der Urologe. Ausg. A 2005;44(12):1435-8.
2005: Margitta Retz; Sukhvinder S Sidhu; Jan Lehmann; H Tamamura; N Fujii; Carol Basbaum
New HIV-drug inhibits in vitro bladder cancer migration and invasion.
European urology 2005;48(6):1025-30.
2005: Jan Lehmann; Michael Stöckle
[Therapy for systemic urothelial cancer recurrence].
Der Urologe. Ausg. A 2005;44(4):369-74.
2005: Margitta Retz; Sukhvinder S Sidhu; Ekaterina Blaveri; Sheena C Kerr; Gregory M Dolganov; Jan Lehmann; Peter Carroll; Jeff Simko; Frederic M Waldman; Carol Basbaum
CXCR4 expression reflects tumor progression and regulates motility of bladder cancer cells.
International journal of cancer. Journal international du cancer 2005;114(2):182-9.
2005: Stefan Siemer; Jan Lehmann; Annemie Christiane Loch; Frank Becker; U Stein; G Schneider; M Ziegler; Michael Stöckle
Current TNM classification of renal cell carcinoma evaluated: revising stage T3a.
The Journal of urology 2005;173(1):33-7.
2004: Tillmann Loch; Ursula Eppelmann; Jan Lehmann; Bernd Wullich; Annemie Christiane Loch; Michael Stöckle
Transrectal ultrasound guided biopsy of the prostate: random sextant versus biopsies of sono-morphologically suspicious lesions.
World journal of urology 2004;22(5):357-60.
2004: Jan Lehmann; Margitta Retz; Nils Nürnberg; Uta Schnöckel; Uta Raffenberg; Matthias Krams; Udo Kellner; Stefan Siemer; Klaus Weichert-Jacobsen; Michael Stöckle
The superior prognostic value of humoral factors compared with molecular proliferation markers in renal cell carcinoma.
Cancer 2004;101(7):1552-62.
2004: Stefan Siemer; Jan Lehmann; Joern Kamradt; T Loch; K Remberger; Ulrich Humke; M Ziegler; Michael Stöckle
Adrenal metastases in 1635 patients with renal cell carcinoma: outcome and indication for adrenalectomy.
The Journal of urology 2004;171(6 Pt 1):2155-9; discussion 2159.
2004: Margitta Retz; Jan Lehmann; Celine Szysnik; Stephanie Zwank; Thorsten Venzke; Christian Röder; Holger Kalthoff; Carol Basbaum; Michael Stöckle
Detection of occult tumor cells in lymph nodes from bladder cancer patients by MUC7 nested RT-PCR.
European urology 2004;45(3):314-9.
2004: Ulrike Zwergel; Jan Lehmann; Bernd Wullich; Ulrich Schreier; Klaus Remberger; Thomas Zwergel; Michael Stoeckle
Lymph node positive prostate cancer: long-term survival data after radical prostatectomy.
The Journal of urology 2004;171(3):1128-31.
2004: Stefan Siemer; Jan Lehmann; Harald Reinhard; Norbert Graf; Gerhard Löffler; Hand Hendrik; Klaus Remberger; Michael Stöckle
Prenatal diagnosis of congenital mesoblastic nephroma associated with renal hypertension in a premature child.
International journal of urology : official journal of the Japanese Urological Association 2004;11(1):50-2.
2003: Jan Lehmann; Margitta Retz; M Hack; Stefan Siemer; Michael Stöckle
[Systemic chemotherapy for transitional cell carcinoma of the urothelium].
Onkologie 2003;26 Suppl 4():18-25.
2003: Jan Lehmann; Margitta Retz; Michael Stöckle
Is there standard chemotherapy for metastatic bladder cancer? Quality of life and medical resources utilization based on largest to date randomized trial.
Critical reviews in oncology/hematology 2003;47(2):171-9.
2003: Joern Kamradt; Carsten Drosse; Sascha Kalkbrenner; Volker Rohde; Ramona Lensch; Jan Lehmann; Thomas Fixemer; Helmut Bonkhoff; Michael Stoeckle; Bernd Wullich
Telomerase activity and telomerase subunit gene expression levels are not related in prostate cancer: a real-time quantification and in situ hybridization study.
Laboratory investigation; a journal of technical methods and pathology 2003;83(5):623-33.
2003: Jan Lehmann; Margitta Retz; C Lippert; P Albers; Michael Stöckle
[Gemcitabine in advanced bladder cancer].
Der Urologe. Ausg. A 2003;42(1):63-77.
2003: Margitta Retz; Jan Lehmann; E Amann; Bernd Wullich; Christian Röder; Michael Stöckle
Mucin 7 and cytokeratin 20 as new diagnostic urinary markers for bladder tumor.
The Journal of urology 2003;169(1):86-9.
2002: Jan Lehmann; Margitta Retz; Stefan Siemer; Joern Kamradt; Bernd Wullich; Michael Stöckle
Managing locally advanced bladder cancer.
Expert review of anticancer therapy 2002;2(6):656-66.
2002: Ramona Lensch; Claudia Götz; Christine Andres; Axel Bex; Jan Lehmann; Thomas Zwergel; Gerhard Unteregger; Joern Kamradt; Michael Stoeckle; Bernd Wullich
Comprehensive genotypic analysis of human prostate cancer cell lines and sublines derived from metastases after orthotopic implantation in nude mice.
International journal of oncology 2002;21(4):695-706.
2002: Jan Lehmann; Margitta Retz; Jürgen Harder; Matthias Krams; Udo Kellner; Julia Hartmann; Kerstin Hohgräwe; Uta Raffenberg; Martin Gerber; Tillmann Loch; Klaus Weichert-Jacobsen; Michael Stöckle
Expression of human beta-defensins 1 and 2 in kidneys with chronic bacterial infection.
BMC infectious diseases 2002;2():20.
2002: Jan Lehmann; Margitta Retz; Michael Stöckle
Chemotherapy in the post-MVAC era: the case for adjuvant chemotherapy.
World journal of urology 2002;20(3):144-50.
2002: Harry Derouet; Jan Lehmann; Bettina Stamm; Christof Lühl; Dirk Römer; Thomas Georg; Elke Isenberg; Thomas Gebhardt; Michael Stoeckle
Age dependent secretion of LH and ACTH in healthy men and patients with erectile dysfunction.
European urology 2002;41(2):144-53; discussion 153-4.
2002: Friedrich P Paulsen; Thomas Pufe; Ulrich Schaudig; Janka Held-Feindt; Jan Lehmann; Andreas B Thale; Bernhard Tillmann
Protection of human efferent tear ducts by antimicrobial peptides.
Advances in experimental medicine and biology 2002;506(Pt A):547-53.
2001: Friedrich P Paulsen; Thomas Pufe; Ulrich Schaudig; Janka Held-Feindt; Jan Lehmann; Jens Schröder; Bernhard Tillmann
Detection of natural peptide antibiotics in human nasolacrimal ducts.
Investigative ophthalmology & visual science 2001;42(10):2157-63.
2001: Margitta Retz; Jan Lehmann; Christian Röder; Klaus Weichert-Jacobsen; Tillmann Loch; E Romahn; C Lühl; Holger Kalthoff; Michael Stöckle
Cytokeratin-20 reverse-transcriptase polymerase chain reaction as a new tool for the detection of circulating tumor cells in peripheral blood and bone marrow of bladder cancer patients.
European urology 2001;39(5):507-15; discussion 516-7.
2001: S Schmidt; M Franke; Jan Lehmann; Tillmann Loch; Michael Stöckle; Klaus Weichert-Jacobsen
Prostate-specific antigen in female urine: a prospective study involving 217 women.
Urology 2001;57(4):717-20.
2000: Jan Lehmann; M Ritz; Nils Nürnberg; E Romahn; S Bach; F Küppers; Tillmann Loch; Michael Stöckle; Klaus Weichert-Jacobsen
Retroperitoneal mature teratoma 15 years after initial treatment of testicular mixed germ cell tumor.
European urology 2000;38(5):644-8.
2000: Jan Lehmann; C Jancke; Margitta Retz; Tillmann Loch; F Küppers; Michael Stöckle; Klaus Weichert-Jacobsen
A hypoechoic lesion found on testicular ultrasound after testicular piercing.
The Journal of urology 2000;164(5):1651.
2000: Margitta Retz; Jan Lehmann; C Trocha; Tillmann Loch; U Seppelt; C Fischer; F A Pinkenburg; K J Timm; Stefan Wellek; Michael Stöckle
Long term follow-up of combined radiochemotherapy for locally advanced bladder carcinoma.
Cancer 2000;89(5):1089-94.
2000: Tillmann Loch; I Leuschner; C Genberg; Klaus Weichert-Jacobsen; F Küppers; Margitta Retz; Jan Lehmann; E Yfantis; M Evans; V Tsarev; Michael Stöckle
[Improvement of transrectal ultrasound. Artificial neural network analysis (ANNA) in detection and staging of prostatic carcinoma].
Der Urologe. Ausg. A 2000;39(4):341-7.
1998: Margitta Retz; Jan Lehmann; Christian Röder; B Plötz; Jürgen Harder; J Eggers; J Pauluschke; Holger Kalthoff; Michael Stöckle
Differential mucin MUC7 gene expression in invasive bladder carcinoma in contrast to uniform MUC1 and MUC2 gene expression in both normal urothelium and bladder carcinoma.
Cancer research 1998;58(24):5662-6.